Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36511784

Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2023 Jan 26
First author
Brown JR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2023 Feb;20(2):64. doi: 10.1038/s41571-022-00724-z.
    note
    Source null
    related pmid
    36543933
    relationship
    Comment in
  2. citation
    N Engl J Med. 2023 May 4;388(18):1719-1720. doi: 10.1056/NEJMc2302350.
    note
    Source null
    related pmid
    37133595
    relationship
    Comment in
  3. citation
    N Engl J Med. 2023 May 4;388(18):1720. doi: 10.1056/NEJMc2302350.
    note
    Source null
    related pmid
    37133596
    relationship
    Comment in
  4. citation
    N Engl J Med. 2023 May 4;388(18):1720-1721. doi: 10.1056/NEJMc2302350.
    note
    Source null
    related pmid
    37133597
    relationship
    Comment in

Authors and identifiers

  1. name
    Brown JR
    type
    Author
  2. name
    Eichhorst B
    type
    Author
  3. name
    Hillmen P
    type
    Author
  4. name
    Jurczak W
    type
    Author
  5. name
    Kaźmierczak M
    type
    Author
  6. name
    Lamanna N
    type
    Author
  7. name
    O'Brien SM
    type
    Author
  8. name
    Tam CS
    type
    Author
  9. name
    Qiu L
    type
    Author
  10. name
    Zhou K
    type
    Author
  11. name
    Simkovic M
    type
    Author
  12. name
    Mayer J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Brown JR
    type
    Author
  2. name
    Eichhorst B
    type
    Author
  3. name
    Hillmen P
    type
    Author
  4. name
    Jurczak W
    type
    Author
  5. name
    Kaźmierczak M
    type
    Author
  6. name
    Lamanna N
    type
    Author
  7. name
    O'Brien SM
    type
    Author
  8. name
    Tam CS
    type
    Author
  9. name
    Qiu L
    type
    Author
  10. name
    Zhou K
    type
    Author
  11. name
    Simkovic M
    type
    Author
  12. name
    Mayer J
    type
    Author
bibliography ids
  1. nci-bib-cceef42d4e58d313cff243dd
book metadata
content sha256
be8ab0b2d1f4f602fb915784ea9b6055ea5b66af17cd93f45a022f487987180f
document type
citation
dois
  1. 10.1056/NEJMoa2211582
electronic publication date
display
2022 Dec 13
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:36511784
immutable id
pubmed:36511784@be8ab0b2d1f4f602fb915784ea9b6055ea5b66af17cd93f45a022f487987180f
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
4
name
The New England journal of medicine
nlm unique id
0255562
pages
319-332
volume
388
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2023 Feb;20(2):64. doi: 10.1038/s41571-022-00724-z.
    note
    Source null
    related pmid
    36543933
    relationship
    Comment in
  2. citation
    N Engl J Med. 2023 May 4;388(18):1719-1720. doi: 10.1056/NEJMc2302350.
    note
    Source null
    related pmid
    37133595
    relationship
    Comment in
  3. citation
    N Engl J Med. 2023 May 4;388(18):1720. doi: 10.1056/NEJMc2302350.
    note
    Source null
    related pmid
    37133596
    relationship
    Comment in
  4. citation
    N Engl J Med. 2023 May 4;388(18):1720-1721. doi: 10.1056/NEJMc2302350.
    note
    Source null
    related pmid
    37133597
    relationship
    Comment in
outcomes validated
false
pmid
36511784
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
89db18160250e4dc0da8d11ad0dc439adba1ce8e7cefa1ece2b71a4a03bdcac6
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 Jan 26
precision
day
year
2023
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36511784/
title
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.

Preserved source evidence · Not medical advice